BioNTech SE (BNTX) Non Operating Income (2020 - 2025)
BioNTech SE (BNTX) posted Non Operating Income of $111.4 million for Q2 2025, up 19.38% sequentially from $93.3 million in Q1 2025, and down 35.52% YoY from $172.7 million in Q2 2024.
BioNTech SE (BNTX) Non Operating Income (2020 - 2025) Analysis & Trends
BioNTech SE has reported Non Operating Income for 6 years, with the latest figure at $111.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 111.38 Mn |
| Mar 31, 2025 | 93.30 Mn |
| Sep 30, 2024 | 162.76 Mn |
| Jun 30, 2024 | 172.73 Mn |
| Mar 31, 2024 | 190.55 Mn |
| Sep 30, 2023 | 167.97 Mn |
| Jun 30, 2023 | 164.54 Mn |
| Mar 31, 2023 | 57.21 Mn |
| Sep 30, 2022 | 113.63 Mn |
| Jun 30, 2022 | 304.43 Mn |
| Mar 31, 2022 | 320.20 Mn |
| Sep 30, 2021 | 66.16 Mn |
| Jun 30, 2021 | 211.47 Mn |
| Mar 31, 2021 | 24.00 Mn |
| Sep 30, 2020 | 24.65 Mn |